The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized study to assess colonic microbiome changes in response to energy drink consumption (ROSANNA trial).
 
Tim Jang
No Relationships to Disclose
 
Doga Kahramangil
No Relationships to Disclose
 
Ji-Hyun Lee
No Relationships to Disclose
 
George P. Kim
Employment - Ipsen (I)
Honoraria - Exelixis; Ipsen
Consulting or Advisory Role - Exelixis
Speakers' Bureau - Ipsen
 
Sherise C. Rogers
Consulting or Advisory Role - Natera
 
Ilyas Sahin
No Relationships to Disclose
 
Brian Hemendra Ramnaraign
Consulting or Advisory Role - Cardinal Health; Ipsen; Merck; Pfizer
 
Krista P. Terracina
No Relationships to Disclose
 
Johan Nordenstam
No Relationships to Disclose
 
Thomas Read
No Relationships to Disclose
 
Ryan M. Thomas
No Relationships to Disclose
 
Ye Yang
No Relationships to Disclose
 
Christian Jobin
Stock and Other Ownership Interests - Evelo Therapeutics
Consulting or Advisory Role - EverImmune SAS
 
Thomas J. George
Consulting or Advisory Role - Avammune Therapeutics; BillionToOne; KAHR Medical; Nihon Medi-Physics; Seagen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BillionToOne (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Elicio Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Ipsen (Inst); Jounce Therapeutics (Inst); Lilly (Inst); Merck (Inst); OncoC4 (Inst); Seagen (Inst)